StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Trading Down 1.5 % Shares of NASDAQ VBLT opened at $0.17 on Thursday. The firm has a market capitalization of $12.09 […]
StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a report published on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ:VBLT opened at $0.18 on Wednesday. The stock’s fifty day moving average is $0.16 and its two-hundred day moving average is $0.15. […]
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ:VBLT opened at $0.19 on Tuesday. The stock’s 50-day moving average is $0.16 and its 200-day […]
StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance NASDAQ:VBLT opened at $0.16 on Monday. The firm has a market capitalization of $11.15 million, a price-to-earnings ratio of […]
Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 698,700 shares, a decline of 43.7% from the February 28th total of 1,240,000 shares. Currently, 1.3% of the shares of the stock are short sold. Based on […]